XML 28 R13.htm IDEA: XBRL DOCUMENT

Note 7 - Marketable Securities

12 Months Ended

Dec. 31, 2023

Notes to Financial Statements

Cash, Cash Equivalents, and Marketable Securities [Text Block]

7.	MARKETABLE SECURITIES

At December 31, 2023, the Company held no marketable equity or trust preferred (debt) securities. The previous sale of these securities was recorded as a component of net income with a gain of $575 in the year ended December 31, 2023. At December 31, 2022, the Company had investments in certain marketable equity and debt securities which had a fair market value of $37,126. These investments were classified as current assets in the consolidated balance sheets.

The Company had designated the trust preferred securities as being available-for-sale. Accordingly, these securities were recorded at fair value of $3,675 at December 31, 2022, with the unrealized loss of $1 and an unrealized gain of $226, net of taxes, as a component of stockholders' equity.

For the years ended December 31, 2022 and 2021, in accordance with ASC 321, the change in the fair value of equity securities (preferred and other equity instruments) was reported as a loss on marketable securities as a component of net income in the amount of $8,297 and $904, respectively.

In 2023, 2022, and 2021, the Company had no recategorized net gain or loss to report from accumulated other comprehensive income.